Clinical Trials
5 trialsNCT01686607 2024-10-21
MYCOS
Astellas Pharma Inc
Completed
NCT04743544 2021-02-08
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy
Dokuz Eylul University
Unknown
NCT04547335 2020-09-16
The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole
Dokuz Eylul University
Unknown
NCT01148160 2014-04-10
Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy
Asan Medical Center
Terminated
NCT01480219 2013-03-11
Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g
Pfizer
Completed